These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 22977165

  • 1. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
    Fretellier N, Bouzian N, Parmentier N, Bruneval P, Jestin G, Factor C, Mandet C, Daubiné F, Massicot F, Laprévote O, Hollenbeck C, Port M, Idée JM, Corot C.
    Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
    [Abstract] [Full Text] [Related]

  • 2. Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.
    Fretellier N, Idée J, Bruneval P, Guerret S, Daubiné F, Jestin G, Factor C, Poveda N, Dencausse A, Massicot F, Laprévote O, Mandet C, Bouzian N, Port M, Corot C.
    Br J Pharmacol; 2012 Feb; 165(4b):1151-62. PubMed ID: 21740412
    [Abstract] [Full Text] [Related]

  • 3. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
    Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J.
    Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226
    [Abstract] [Full Text] [Related]

  • 4. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D, Johnsen H, Juelsrud A, Løvhaug D.
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [Abstract] [Full Text] [Related]

  • 5. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 6. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J, Frisk AL, Frenzel T, Schöckel L, Rosenbruch M, Jost G, Lenhard DC, Sieber MA, Nischwitz V, Küppers A, Pietsch H.
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [Abstract] [Full Text] [Related]

  • 7. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
    Fretellier N, Rasschaert M, Bocanegra J, Robert P, Factor C, Seron A, Idée JM, Corot C.
    Invest Radiol; 2021 Dec 01; 56(12):826-836. PubMed ID: 34091462
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study.
    Fretellier N, Idée JM, Dencausse A, Karroum O, Guerret S, Poveda N, Jestin G, Factor C, Raynal I, Zamia P, Port M, Corot C.
    Invest Radiol; 2011 May 01; 46(5):292-300. PubMed ID: 21263333
    [Abstract] [Full Text] [Related]

  • 9. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H, Lengsfeld P, Steger-Hartmann T, Löwe A, Frenzel T, Hütter J, Sieber MA.
    Invest Radiol; 2009 Apr 01; 44(4):226-33. PubMed ID: 19252439
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.
    Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC.
    Radiology; 2009 Nov 01; 253(2):390-8. PubMed ID: 19789237
    [Abstract] [Full Text] [Related]

  • 11. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T, Ito K, Tamada T, Kanki A, Watanabe S, Nishimura H, Tanimoto D, Higashi H, Yamamoto A.
    Magn Reson Imaging; 2013 Oct 01; 31(8):1412-7. PubMed ID: 23643157
    [Abstract] [Full Text] [Related]

  • 12. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N, Granottier A, Rasschaert M, Grindel AL, Baudimont F, Robert P, Idée JM, Corot C.
    Invest Radiol; 2019 Feb 01; 54(2):61-71. PubMed ID: 30394964
    [Abstract] [Full Text] [Related]

  • 13. Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model.
    Kartamihardja AAP, Amalia SN, Sekiguchi A, Bhattarai A, Taketomi-Takahashi A, Motegi SI, Koyama H, Tsushima Y.
    PLoS One; 2021 Feb 01; 16(10):e0259211. PubMed ID: 34705860
    [Abstract] [Full Text] [Related]

  • 14. Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.
    Haylor J, Schroeder J, Wagner B, Nutter F, Jestin G, Idée JM, Morcos S.
    Radiology; 2012 Apr 01; 263(1):107-16. PubMed ID: 22344402
    [Abstract] [Full Text] [Related]

  • 15. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N, Salhi M, Schroeder J, Siegmund H, Chevalier T, Bruneval P, Jestin-Mayer G, Delaloge F, Factor C, Mayer JF, Fabicki JM, Robic C, Bonnemain B, Idée JM, Corot C.
    Eur J Pharm Sci; 2015 May 25; 72():46-56. PubMed ID: 25736527
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.
    Hope TA, Leboit PE, High WA, Fu Y, Brasch RC.
    Magn Reson Imaging; 2013 Jan 25; 31(1):139-44. PubMed ID: 22898683
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.
    Pietsch H, Pering C, Lengsfeld P, Walter J, Steger-Hartmann T, Golfier S, Frenzel T, Hütter J, Weinmann HJ, Sieber MA.
    J Magn Reson Imaging; 2009 Aug 25; 30(2):374-83. PubMed ID: 19629978
    [Abstract] [Full Text] [Related]

  • 18. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb 25; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

  • 19. In an animal model nephrogenic systemic fibrosis cannot be induced by intraperitoneal injection of high-dose gadolinium based contrast agents.
    Langer RD, Lorke DE, Neidl van Gorkom KF, Petroianu G, Azimullah S, Nurulain SM, Singh S, Fuchsjäger M.
    Eur J Radiol; 2012 Oct 25; 81(10):2562-7. PubMed ID: 22304979
    [Abstract] [Full Text] [Related]

  • 20. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.
    Idée JM, Fretellier N, Robic C, Corot C.
    Crit Rev Toxicol; 2014 Nov 25; 44(10):895-913. PubMed ID: 25257840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.